GL1X · GenesisL1 explorer

Research workbench

GSK3B in complex with inhibitor

Analyse GSK3B in complex with inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4ACD
Type
protein
Length
700 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glycogen synthase kinase-3 beta
EC
2.7.11.1, 2.7.11.26
UniProt
P49841
Ligands
GR9
Pockets
8 · best druggability 0.79

Structure

x-ray diffraction · 1 distinct chain · 34% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BGlycogen synthase kinase-3 beta (EC 2.7.11.1, 2.7.11.26)protein35034% helix, 18% strandP49841

Ligands and binding sites

  • GR9 · 3-amino-6-{4-[(4-methylpiperazin-1-yl)sulfonyl]phenyl}-N-pyridin-3-ylpyrazine-2-carboxamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110310.790.8181GR9
29350.790.8172GR9
3890.760.9830empty
41050.460.7923empty
51530.430.7529empty

Interfaces

1 interface between chains.

  • A–B · 1473 Ų buried · 19 hydrogen bonds · protein-protein

Compared structures

  • 4ACD · GSK3b in complex with inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.